{"ticker": {"uuid": "50333981-ad12-4c5d-9033-0d6c34285d29", "symbol": "6938", "name": "Suzhou Ribo Life Science Co", "exchange": "HKG", "country": "HK", "sector": "Healthcare", "industry": "Biotechnology"}, "articles": [{"title": "Suzhou Ribo Life Science Signals Confidence With HK$9.3 Million Share Buyback", "summary": "", "url": "https://news.google.com/rss/articles/CBMixwFBVV95cUxQSTNPUTNFZGxaWU5nNU5JZWRxQWhjbE0zVG93Z2NXZkVpYlJiV0RxTVBlNE5ndllRbURYOHVnVVduUVp0VkpoUEdaU2VUR3RINTdSNFFHdUItRmhUTGdBajFnTDFoR3lGREhfNEluLTh1NDFmTmZXVmZzYjVkbHJPNDVCZ2lMTTAxODFqMHpDZXQ2TlV5cTdIMVpEcXNRcG5aSGFwVjh1RG4yTzdNeWxmQUh3VzhOOURGTDNNbjhadFlrYjRZOFhz?oc=5", "source_name": "TipRanks", "published_at": "2026-07-13T14:14:51+00:00", "published_display": "13 Jul 2026 14:14", "sentiment": "positive", "sentiment_pct": 62, "event_type": "capital_return", "event_label": "Capital return", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Suzhou Ribo Executive Boosts Stake in H Shares, Signalling Confidence in Growth Prospects", "summary": "", "url": "https://news.google.com/rss/articles/CBMi1wFBVV95cUxNWkJJblhSWTIwVkxmX2dYZHgwUDJZVGdiUWRER3BlUGlIMU40cUZIZFRKMDFkRXZEQWR3bml0Sm1oZGdVLVFKMG80bGRDaHBXQl9aWmtyb1NNdHQ5RmsyVUN4V0NtdWl0ZW9fUUItQVVkWWtZejR0WHJRRjVEM3JhRExLcTR3NDQ2Zk9iT2k4eThHOC0ySWhFZjBCVWMycWE0T0R6M0xfQ0htdUFBSHNUZ1Rpck1XdUVyZkFqYW5CUENCcTN1a3Rhd2JtdU5yR0lyZ0tPNEh2MA?oc=5", "source_name": "TipRanks", "published_at": "2026-07-10T10:41:19+00:00", "published_display": "10 Jul 2026 10:41", "sentiment": "positive", "sentiment_pct": 66, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Suzhou Ribo Hits First Milestone in Madrigal siRNA Liver Disease Partnership", "summary": "", "url": "https://news.google.com/rss/articles/CBMixwFBVV95cUxPaWRKSTR5U19jcHBieXRJMkMwYWZHVGJCWFgzVEVGem43U1FoNkREWUJkbWhMNTlNN1dMTnpCdFl3aUdPVFU3Qi1ic3hzeFhFZ1o4YWc0Q2xINGVJNFplNEZHd1NjSWc2WjNWNWhuY19udmhsWXFJcEZKTDBDNVNXX1hETk9nU1FyQW1aTTRVdENLbl80bW9EQ19uNks2aVIyVG5iWW8xVWMzeEIwemYxN1JJMGRCNzlzcGRhTldMRlFEb3ZEMUtz?oc=5", "source_name": "TipRanks", "published_at": "2026-07-01T07:00:00+00:00", "published_display": "01 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "NEWS WRAP: Ribo Life enters Hong Kong biotech fast lane after strong debut", "summary": "", "url": "https://news.google.com/rss/articles/CBMiowFBVV95cUxPcDdob1lQTUFJenhfUjJrdEtDazI0emZFQjVfR3lob2sxMlV4eE5aX190akxhelJtOVBXMXExb004Ty1Fc3RhWnlQTjc3Z2FFdGF5YmpENlZwcmJHa0IwY3RTMnJTSFZtOTZXVFAxMC1seWE1dkhKUmJKVXg4ajFIM3dUODZnQ2tQTldtZXdVcGJ5dGFGVW92Um9rdTZfMlUycXZR?oc=5", "source_name": "thebambooworks.com", "published_at": "2026-01-16T08:00:00+00:00", "published_display": "16 Jan 2026 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Ribo Life Science (06938.HK) Successfully Lists on the Main Board of the Hong Kong Stock Exchange", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5AFBVV95cUxNQ1l3dWtFOWI1cWo1Q2ZWLS1Yc3BuNzVKeTJzemVaczJYMjJzc1V0NG5PU2xseHpfYkFqNzBta3hTSV91SjBEcnNTdURZWVFfNHhUaFp1V1RVYkhJQ1VPSTE1Vk9MOS1iV3RBZWVBUE1MVU1LOFl3ODlRTGpJMERuaGhaU0QxQ1lyTzEtNG9OMTlFTDZIV29yZ1NoeU10UzlfVVpHc0I2aEEtY3BPaU5JdVhEUUFKZ0p2TS1JWVF6WkxZVlZqWXFIOEMwWm5zZFBrVkUydTlsMDNwZFFEVXRubXBybW8?oc=5", "source_name": "PR Newswire", "published_at": "2026-01-09T08:00:00+00:00", "published_display": "09 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Suzhou Ribo Life Science Co. Ltd. Class H Financial Statements \u2013 HKEX:6938", "summary": "", "url": "https://news.google.com/rss/articles/CBMidEFVX3lxTE1lR3BRaUVxUTdfNWx5dmZSSk1XZmJxOTRfd21IbXZwZ3lXazFld1dsbEpOU2ZaM2M0RjJVSXIzNEdLbUZIMmNnRUliYlZDaHpBMnNhRFVNQzZoUm16SzJwblRMMDhXaWJzMmJoN09zT3N6NUNx?oc=5", "source_name": "TradingView", "published_at": "2026-01-09T03:12:30+00:00", "published_display": "09 Jan 2026 03:12", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Suzhou Ribo Life Science Signals Confidence With HK$9.3 Million Share Buyback", "summary": "", "url": "https://news.google.com/rss/articles/CBMixwFBVV95cUxQSTNPUTNFZGxaWU5nNU5JZWRxQWhjbE0zVG93Z2NXZkVpYlJiV0RxTVBlNE5ndllRbURYOHVnVVduUVp0VkpoUEdaU2VUR3RINTdSNFFHdUItRmhUTGdBajFnTDFoR3lGREhfNEluLTh1NDFmTmZXVmZzYjVkbHJPNDVCZ2lMTTAxODFqMHpDZXQ2TlV5cTdIMVpEcXNRcG5aSGFwVjh1RG4yTzdNeWxmQUh3VzhOOURGTDNNbjhadFlrYjRZOFhz?oc=5", "source_name": "TipRanks", "published_at": "2026-07-13T14:14:51+00:00", "published_display": "13 Jul 2026 14:14", "sentiment": "positive", "sentiment_pct": 62, "event_type": "capital_return", "event_label": "Capital return", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Suzhou Ribo Executive Boosts Stake in H Shares, Signalling Confidence in Growth Prospects", "summary": "", "url": "https://news.google.com/rss/articles/CBMi1wFBVV95cUxNWkJJblhSWTIwVkxmX2dYZHgwUDJZVGdiUWRER3BlUGlIMU40cUZIZFRKMDFkRXZEQWR3bml0Sm1oZGdVLVFKMG80bGRDaHBXQl9aWmtyb1NNdHQ5RmsyVUN4V0NtdWl0ZW9fUUItQVVkWWtZejR0WHJRRjVEM3JhRExLcTR3NDQ2Zk9iT2k4eThHOC0ySWhFZjBCVWMycWE0T0R6M0xfQ0htdUFBSHNUZ1Rpck1XdUVyZkFqYW5CUENCcTN1a3Rhd2JtdU5yR0lyZ0tPNEh2MA?oc=5", "source_name": "TipRanks", "published_at": "2026-07-10T10:41:19+00:00", "published_display": "10 Jul 2026 10:41", "sentiment": "positive", "sentiment_pct": 66, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Suzhou Ribo Hits First Milestone in Madrigal siRNA Liver Disease Partnership", "summary": "", "url": "https://news.google.com/rss/articles/CBMixwFBVV95cUxPaWRKSTR5U19jcHBieXRJMkMwYWZHVGJCWFgzVEVGem43U1FoNkREWUJkbWhMNTlNN1dMTnpCdFl3aUdPVFU3Qi1ic3hzeFhFZ1o4YWc0Q2xINGVJNFplNEZHd1NjSWc2WjNWNWhuY19udmhsWXFJcEZKTDBDNVNXX1hETk9nU1FyQW1aTTRVdENLbl80bW9EQ19uNks2aVIyVG5iWW8xVWMzeEIwemYxN1JJMGRCNzlzcGRhTldMRlFEb3ZEMUtz?oc=5", "source_name": "TipRanks", "published_at": "2026-07-01T07:00:00+00:00", "published_display": "01 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "NEWS WRAP: Ribo Life enters Hong Kong biotech fast lane after strong debut", "summary": "", "url": "https://news.google.com/rss/articles/CBMiowFBVV95cUxPcDdob1lQTUFJenhfUjJrdEtDazI0emZFQjVfR3lob2sxMlV4eE5aX190akxhelJtOVBXMXExb004Ty1Fc3RhWnlQTjc3Z2FFdGF5YmpENlZwcmJHa0IwY3RTMnJTSFZtOTZXVFAxMC1seWE1dkhKUmJKVXg4ajFIM3dUODZnQ2tQTldtZXdVcGJ5dGFGVW92Um9rdTZfMlUycXZR?oc=5", "source_name": "thebambooworks.com", "published_at": "2026-01-16T08:00:00+00:00", "published_display": "16 Jan 2026 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Ribo Life Science (06938.HK) Successfully Lists on the Main Board of the Hong Kong Stock Exchange", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5AFBVV95cUxNQ1l3dWtFOWI1cWo1Q2ZWLS1Yc3BuNzVKeTJzemVaczJYMjJzc1V0NG5PU2xseHpfYkFqNzBta3hTSV91SjBEcnNTdURZWVFfNHhUaFp1V1RVYkhJQ1VPSTE1Vk9MOS1iV3RBZWVBUE1MVU1LOFl3ODlRTGpJMERuaGhaU0QxQ1lyTzEtNG9OMTlFTDZIV29yZ1NoeU10UzlfVVpHc0I2aEEtY3BPaU5JdVhEUUFKZ0p2TS1JWVF6WkxZVlZqWXFIOEMwWm5zZFBrVkUydTlsMDNwZFFEVXRubXBybW8?oc=5", "source_name": "PR Newswire", "published_at": "2026-01-09T08:00:00+00:00", "published_display": "09 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Suzhou Ribo Life Science Co. Ltd. Class H Financial Statements \u2013 HKEX:6938", "summary": "", "url": "https://news.google.com/rss/articles/CBMidEFVX3lxTE1lR3BRaUVxUTdfNWx5dmZSSk1XZmJxOTRfd21IbXZwZ3lXazFld1dsbEpOU2ZaM2M0RjJVSXIzNEdLbUZIMmNnRUliYlZDaHpBMnNhRFVNQzZoUm16SzJwblRMMDhXaWJzMmJoN09zT3N6NUNx?oc=5", "source_name": "TradingView", "published_at": "2026-01-09T03:12:30+00:00", "published_display": "09 Jan 2026 03:12", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 76, "total_relevant": 6, "sentiment_summary": {"positive": 3, "negative": 0, "neutral": 3, "score": 58, "total": 6, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 68, "events": [{"event": "general", "label": "Market update", "weight": 1.65, "count": 3}, {"event": "deals", "label": "Deals and strategy", "weight": 1.1, "count": 2}, {"event": "capital_return", "label": "Capital return", "weight": 0.55, "count": 1}], "positive_events": 3, "negative_events": 0}, "market_context": {"has_market_context": true, "latest_close": 48.24, "latest_week": "2026-07-10", "one_week_move": -5.5, "four_week_move": -5.4, "twelve_week_move": -26.8, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": 0.0, "market_dynamics_buy_signal": false, "relative_strength": null, "fair_value_gap": -22.2, "fair_value_label": "Below fair value", "fair_value_tone": "positive", "expectation_direction": "negative", "expectation_probability": 44.382, "reaction_label": "Price reacting lower", "reaction_tone": "negative", "market_sentence": "-5.5% over one week, -5.4% over four weeks, trend inactive, and below fair value."}, "interpretation": {"label": "Price moving ahead of tone", "tone": "negative", "classification": "price_leads_news", "summary": "Price is moving more forcefully than the current news tone suggests.", "confidence": 63, "badges": ["Value support"], "opportunities": ["Price is below fair value while news tone is not negative."], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "TipRanks", "count": 3}, {"label": "thebambooworks.com", "count": 1}, {"label": "PR Newswire", "count": 1}, {"label": "TradingView", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 6}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 3}, {"label": "Deals and strategy", "count": 2}, {"label": "Capital return", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "58/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Price moving ahead of tone", "tone": "negative", "text": "Price is moving more forcefully than the current news tone suggests."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "68/100 classification confidence."}, {"label": "Company focus", "value": "6", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "0", "tone": "neutral", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "-5.5% over one week, -5.4% over four weeks, trend inactive, and below fair value."}, {"label": "Latest direct headline", "value": "Positive", "tone": "positive", "text": "Suzhou Ribo Life Science Signals Confidence With HK$9.3 Million Share Buyback"}], "updated_at": "2026-07-18T00:03:04.770362+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}